Refractory Crohn's disease complicated with Guillain-Barré syndrome: A case report

Table 1 Treatment and prognosis of inflammatory bowel disease combined with Guillain-Barré syndrome

Ref.	Age/sex	Diagnosis	Drug	Medication and symptoms interval	Treatment	Prognosis
Tominaga et al[15]	39/M	UC	None	None	IVIG	CR
Jayasundara et al[16]	24/M	UC	AZA + prednisolone	Not mentioned	IVIG	PR
Krystallis et al[17]	59/M	UC	Prednisolone + 5-ASA	Not mentioned	IVIG + prednisolone	CR
Liu et al[18]	31/F	UC	5-ASA	Not mentioned	Methylprednisolone	CR
Cesarini et al[20]	72/M	CD	Adalimumab	1 month	IVIG + methylprednisolone	PR
Cançado et al[21]	64/M	CD	Adalimumab	2 weeks	Prednisone	CR
Patwala et al[22]	37/M	CD	Adalimumab	9 months	IVIG	PR
De Azevedo et al[23]	31/M	CD	Vedolizumab	2 weeks	IVIG	Not mentioned
Fukushima et al[24]	32/M	CD	Ustekinumab	1 year	IVIG	PR
Natividade et al[25]	45/M	Psoriasis	Adalimumab	1 year	IVIG	PR
Bouchra et al[26]	47/F	AS	Infliximab	2 months	IVIG	CR
Lee et al[27]	33/F	CD	Adalimumab	2 months	Adalimumab + IVIG	CR

CD: Crohn's disease; UC: Ulcerative colitis; IVIG: Intravenous immunoglobulin; AS: Ankylosing spondylitis; 5-ASA: 5-aminosalicylate; AZA: Azathioprine; CR: Complete remission; PR: Partial remission.